1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
URL returned HTTP 403 Forbidden; page could not be retrieved.
"King Baudouin Foundation – Prize Generet for rare diseases" is currently closed and not accepting applications.
The Prize Generet for Rare Diseases is a grant from the King Baudouin Foundation that funds scientific research aimed at better understanding and treating rare diseases. The award supports projects that improve knowledge of the causes and mechanisms of rare diseases, or that translate fundamental discoveries into better prevention, diagnosis, or treatment for patients.
Eligible applicants include confirmed researchers in rare diseases, as well as researchers with a track record in more common pathologies who can demonstrate substantial added value for rare disease research. International and interdisciplinary collaboration are strongly encouraged. The award provides €1,250,000 for a single project, paid in two phases, with the second phase conditional on a positive midterm review.
The application deadline was April 20, 2026.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
2026 Prize Generet for rare diseases | King Baudouin Foundation This call is launched in partnership with the FRS_FNRS - To apply please click on http://www. generetaward. be Rare diseases are life threatening or chronic conditions which affect no more than 1 person out of 2.
000. Currently many patients are not diagnosed or do not benefit from an appropriate treatment. Scientific research is crucial to improve the quality of life of the patients.
By launching an annual call for projects, the Fund Generet wants to support research on rare diseases with the aim to better understand the processes (causes and mechanisms) underpinning rare diseases and/or to turn fundamental discoveries into better prevention, diagnosis or treatment of patients.
The call is aimed to two categories of researchers: confirmed researchers in rare diseases and confirmed researchers with a track record in more common pathologies who can demonstrate that their research will have a substantial added value for rare diseases and can accelerate research in this particular field. International and interdisciplinary collaboration are strongly encouraged. The annual Generet Award of 1.
250. 000 € for 1 single project aims to catalyse the research agenda on rare diseases in Belgium and beyond. The amount will be paid in 2 phases.
The second support is conditional to a positive midterm review. Part of the budget may be outsourced for supporting international expenses.
According to the current listing, eligibility includes: Confirmed researchers in rare diseases, or confirmed researchers with a track record in more common pathologies who can demonstrate that their research will have a substantial added value for rare diseases and can accel…. Confirm the full requirements in the official notice before applying.
The current listing shows €1,250,000 over four years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was April 20, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
King Baudouin Foundation – Prize Generet for rare diseases is funded by King Baudouin Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Microsoft launched Community-First Grants on September 21, 2026 — $1 million to King County nonprofits, applications through October 23, grantees notified in November. The scope is small and the geography is narrow, but the eligibility gate inverts how corporate philanthropy normally works, and the things the announcement does not specify tell you more than the things it does.
Read articleOn August 25, 2026 a Ninth Circuit panel affirmed most of a sweeping injunction against HUD, DOT, and HHS grant conditions covering roughly $14 billion. The opinion sorts conditions into four buckets — and only one of them holds up. Here is what changed for every recipient of a federal award.
Read article